The Healing Effect of a Two-Herb Recipe on Foot Ulcer in Chinese Patients With Type 2 Diabetes
Primary Purpose
Diabetic Foot Ulcer
Status
Completed
Phase
Phase 2
Locations
China
Study Type
Interventional
Intervention
Chinese herbal medicine (Radix Rehmanniae and Radix Astragali)
Placebo comparator
Sponsored by
About this trial
This is an interventional treatment trial for Diabetic Foot Ulcer focused on measuring Diabetes, foot ulcer, Chinese herbal medicine
Eligibility Criteria
Inclusion Criteria:
Type 2 diabetic subjects with documented evidence of mild diabetic foot ulcer
- Male or female patients attending Diabetic Clinics and/or Podiatry Clinics at the hospitals of the New Territories East Cluster
- Aged between 20 and 75 years old inclusive
- All patients should be on stable dose of medication 4 weeks prior to enrolment
- Written informed consent
- If the patient is a woman of child-bearing potential, she must agree to use adequate method of contraception throughout the study period, unless surgically sterilized.
Exclusion Criteria:
Patients with end-stage renal disease as defined by the need for dialysis or on renal replacement program
- Patients with advanced diabetic eye disease as defined by the history of laser therapy, retinal detachment or vitreous hemorrhage
- Pregnancy, breast feeding, or patient has plans of becoming pregnant during the study period.
- Known allergy to TCM drugs
- Contraindication or intolerance to use of aspirin, statin , ACEI or ARB
- History of major gastrointestinal bleeding in the 5 years prior to consent
- Congestive heart failure of any severity
- Significant cardiovascular disease within 3 months of enrolment including acute coronary syndrome, cardiac revascularization procedure, transient ischemic attack and cerebrovascular accident
- HbA1c ≥ 10%
- Severe liver function impairment (≥ 3 ULN of ALT) and renal impairment (eGFR < 30 ml/min/1.73 m2)
- Investigational drugs within 30 days of enrolment
- Patient taking any Chinese herbal medicine in the 8 weeks prior to enrolment into the study
- Any other medical conditions that is considered as unsuitable for the study by investigator
Sites / Locations
- Diabetes and Endocrine Centre
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Placebo Comparator
Arm Label
Chinese Herbal Medicine
Placebo arm
Arm Description
2 sachets of Chinese Herbal Medicine to be taken daily
2 sachets to be taken daily
Outcomes
Primary Outcome Measures
Resolution/progression of foot ulcer based on PEDIS
Secondary Outcome Measures
Hospital admission/attendance/stay
Full Information
NCT ID
NCT01389362
First Posted
July 6, 2011
Last Updated
July 27, 2011
Sponsor
Chinese University of Hong Kong
1. Study Identification
Unique Protocol Identification Number
NCT01389362
Brief Title
The Healing Effect of a Two-Herb Recipe on Foot Ulcer in Chinese Patients With Type 2 Diabetes
Official Title
The Healing Effect of a Two-Herb Recipe on Foot Ulcer in Chinese Patients With Type 2 Diabetes: A Randomized, Placebo-Controlled Study
Study Type
Interventional
2. Study Status
Record Verification Date
July 2011
Overall Recruitment Status
Completed
Study Start Date
May 2009 (undefined)
Primary Completion Date
May 2011 (Actual)
Study Completion Date
May 2011 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
Chinese University of Hong Kong
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
There is now a global epidemic of diabetes and obesity affecting more than 300 million people worldwide with Asia in the forefront. In Hong Kong, diabetes affects more than 10% of the population. Patients with diabetes have a 12-25% lifetime risk of developing a foot ulcer.The abnormal metabolic milieus of hyperglycemia, hyperlipidemia, hypertension, pro-thrombotic state and chronic inflammation in diabetes causes atherosclerosis.A significant proportion of subjects have underlying peripheral arterial disease and neuropathy. These subjects are at great risk of developing infective foot ulceration secondary to impaired vascular supply, sensory loss and minor trauma.Without prompt and proper medical treatment, these infective ulcers will deteriorate leading to gangrene and limb amputation. In-vitro and in-vivo studies revealed that 5 out of the 12 herbs were effective in promoting fibroblast proliferation and angiogenesis. To minimize potential drug interactions and adverse effects from multiple components in a recipe of Traditional Chinese Medicine (TCM), the investigators have developed a simplified formula from the 12 herbs consisting of only two herbs. In this proof-of-concept study, the investigators hypothesize that the novel recipe of herbal medicine will expedite healing of early foot ulcer by promoting vascularisation and granulation as well as modulating inflammatory response.
Detailed Description
There is now a global epidemic of diabetes and obesity affecting more than 300 million people worldwide with Asia in the forefront. In Hong Kong, diabetes affects more than 10% of the population. Patients with diabetes have a 12-25% lifetime risk of developing a foot ulcer. These silent conditions independently and collectively contribute to 50% of all causes of death mainly due to cardiovascular and renal complications. Type 2 diabetes is a complex disorder characterized by a constellation of cardiovascular risk factors, notably, hyperglycemia, obesity, dyslipidemia (high triglyceride (TG) and low HDL-C), hypertension, microinflammation and prothrombotic state, often referred to as the metabolic syndrome. The public health implication of diabetes lies mainly in its devastating chronic complications due to generalized vascular dysfunction. In patients with diabetes and metabolic syndrome, loss of cellular structure or function due to apoptosis, angiogenesis and fibrosis eventually manifest as overt diabetic complications, such as cardiovascular diseases, neuropathy, retinopathy and nephropathy.
The abnormal metabolic milieus of hyperglycemia, hyperlipidemia, hypertension, pro-thrombotic state and chronic inflammation in diabetes causes atherosclerosis. A significant proportion of subjects have underlying peripheral arterial disease and neuropathy. These subjects are at great risk of developing infective foot ulceration secondary to impaired vascular supply, sensory loss and minor trauma. Without prompt and proper medical treatment, these infective ulcers will deteriorate leading to gangrene and limb amputation. Age, wound depth, the presence of ischaemia, a low albumin level, and the lack of simultaneous ulceration are the most significant independent predictors of an unfavourable outcome. The conventional management of diabetic foot ulcer includes rest, antibiotic therapy, surgical debridement and good glycemic control. The investigators previously demonstrated that the use of a recipe containing 12 herbs was effective in promoting the healing of severe chronic non-healing diabetic foot ulcers and achieved an 85% of limb preservation. In-vitro and in-vivo studies revealed that 5 out of the 12 herbs were effective in promoting fibroblast proliferation and angiogenesis. To minimize potential drug interactions and adverse effects from multiple components in a recipe of Traditional Chinese Medicine (TCM), the investigators have developed a simplified formula from the 12 herbs consisting of only two herbs.
Many herbs have long been used to treat diabetes mellitus and its complications. In many of these successful attempts Radix Rehmanniae (RR) and Radix Astragali (RA) have frequently been used in combination with other herbs to form complex formulae such as 'blood-house blood stasis-dispelling decoction with additive ingredients' and 'pills of six drugs with Rehmannia'.
Based on our previous in-vitro and in-vivo studies, a new reformulated recipe of herbal medicine has been developed. In this proof-of-concept study, the investigators hypothesize that the novel recipe of herbal medicine will expedite healing of early foot ulcer by promoting vascularisation and granulation as well as modulating inflammatory response. Results will provide valuable insight and understanding of the application of TCM in the management of diabetic foot ulcer, in particular, the effect on angiogenesis and anti-inflammation. New intellectual properties will be developed and provide the foundation for future research. Such an integrated approach from bench to bedside will serve as a model platform for the development of TCM in Hong Kong.
The study will investigate whether the two-herb recipe can increase the wound healing of patients with diabetes mellitus.
Primary outcome:
Resolution/progression of foot ulcer based on PEDIS
Failure of treatment i.e. no improvement in 6 months, rapid deterioration or emergency surgery required
Secondary outcome:
Hospital admission/attendance/stay
Metabolic parameters
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetic Foot Ulcer
Keywords
Diabetes, foot ulcer, Chinese herbal medicine
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2, Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
16 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Chinese Herbal Medicine
Arm Type
Active Comparator
Arm Description
2 sachets of Chinese Herbal Medicine to be taken daily
Arm Title
Placebo arm
Arm Type
Placebo Comparator
Arm Description
2 sachets to be taken daily
Intervention Type
Drug
Intervention Name(s)
Chinese herbal medicine (Radix Rehmanniae and Radix Astragali)
Intervention Description
2 sachets to be taken daily
Intervention Type
Drug
Intervention Name(s)
Placebo comparator
Intervention Description
2 sachets to be taken daily
Primary Outcome Measure Information:
Title
Resolution/progression of foot ulcer based on PEDIS
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Hospital admission/attendance/stay
Time Frame
6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Type 2 diabetic subjects with documented evidence of mild diabetic foot ulcer
Male or female patients attending Diabetic Clinics and/or Podiatry Clinics at the hospitals of the New Territories East Cluster
Aged between 20 and 75 years old inclusive
All patients should be on stable dose of medication 4 weeks prior to enrolment
Written informed consent
If the patient is a woman of child-bearing potential, she must agree to use adequate method of contraception throughout the study period, unless surgically sterilized.
Exclusion Criteria:
Patients with end-stage renal disease as defined by the need for dialysis or on renal replacement program
Patients with advanced diabetic eye disease as defined by the history of laser therapy, retinal detachment or vitreous hemorrhage
Pregnancy, breast feeding, or patient has plans of becoming pregnant during the study period.
Known allergy to TCM drugs
Contraindication or intolerance to use of aspirin, statin , ACEI or ARB
History of major gastrointestinal bleeding in the 5 years prior to consent
Congestive heart failure of any severity
Significant cardiovascular disease within 3 months of enrolment including acute coronary syndrome, cardiac revascularization procedure, transient ischemic attack and cerebrovascular accident
HbA1c ≥ 10%
Severe liver function impairment (≥ 3 ULN of ALT) and renal impairment (eGFR < 30 ml/min/1.73 m2)
Investigational drugs within 30 days of enrolment
Patient taking any Chinese herbal medicine in the 8 weeks prior to enrolment into the study
Any other medical conditions that is considered as unsuitable for the study by investigator
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Juliana NA Chan, MBChB, FRCP
Organizational Affiliation
Chinese University of Hong Kong
Official's Role
Principal Investigator
Facility Information:
Facility Name
Diabetes and Endocrine Centre
City
Hong Kong SAR
State/Province
Hong Kong SAR
Country
China
12. IPD Sharing Statement
Citations:
PubMed Identifier
24330156
Citation
Ko CH, Yi S, Ozaki R, Cochrane H, Chung H, Lau W, Koon CM, Hoi SW, Lo W, Cheng KF, Lau CB, Chan WY, Leung PC, Chan JC. Healing effect of a two-herb recipe (NF3) on foot ulcers in Chinese patients with diabetes: a randomized double-blind placebo-controlled study. J Diabetes. 2014 Jul;6(4):323-34. doi: 10.1111/1753-0407.12117. Epub 2014 Feb 24.
Results Reference
derived
Learn more about this trial
The Healing Effect of a Two-Herb Recipe on Foot Ulcer in Chinese Patients With Type 2 Diabetes
We'll reach out to this number within 24 hrs